title: Fluorescence polarization screening for allosteric small molecule ligands of the cholecystokinin receptor.
abstract: The success in screening for drug candidates is highly dependent on the power of the strategy implemented. In this work, we report and characterize a novel fluorescent benzodiazepine antagonist of the type 1 cholecystokinin receptor (3-(3-(7-fluoro-1-(2-isopropyl(4-methoxyphenyl)amino)-2-oxoethyl)-2,4-dioxo-5-phenyl-2,3,4,5-tetrahydro-1H-benzo[b][1,4]-diazepin-3-yl)ureido)benzoic acid) that can be used as a receptor ligand in a fluorescence polarization assay, which is ideally suited for the identification of small molecule allosteric modulators of this physiologically important receptor. By binding directly to the small molecule-docking region within the helical bundle of this receptor, this indicator can be displaced by many small molecule candidate drugs, even those that might not affect the binding of an orthosteric cholecystokinin-like peptide ligand. The biological, pharmacological, and fluorescence properties of this reagent are described, and proof-of-concept is provided in a fluorescence polarization assay utilizing this fluorescent benzodiazepine ligand.
authors.affiliation: Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Scottsdale, Arizona, USA.
authors.forename: Kaleeckal G
authors.initials: KG
authors.lastname: Harikumar
authors.forename: Erin E
authors.initials: EE
authors.lastname: Cawston
authors.forename: Laurence J
authors.initials: LJ
authors.lastname: Miller
mesh_terms: D000495:Allosteric Site; D000818:Animals; D001569:Benzodiazepines / Q000737:chemistry / Q000494:pharmacology; D016466:CHO Cells; D006224:Cricetinae; D020109:Devazepide / Q000378:metabolism / Q000494:pharmacology; D055808:Drug Discovery; D005453:Fluorescence; D005454:Fluorescence Polarization / Q000379:methods*; D006801:Humans; D052139:Intracellular Calcium-Sensing Proteins / Q000378:metabolism; D008024:Ligands; D010455:Peptides; D011485:Protein Binding; D011869:Radioligand Assay; D043886:Receptor, Cholecystokinin A / Q000037:antagonists & inhibitors / Q000378:metabolism; D011949:Receptors, Cholecystokinin / Q000737:chemistry / Q000378:metabolism*; D012844:Sincalide / Q000378:metabolism; D054852:Small Molecule Libraries / Q000032:analysis; D013050:Spectrometry, Fluorescence; D013329:Structure-Activity Relationship
chemical_list: D052139:Intracellular Calcium-Sensing Proteins; D008024:Ligands; D010455:Peptides; D043886:Receptor, Cholecystokinin A; D011949:Receptors, Cholecystokinin; D054852:Small Molecule Libraries; D001569:Benzodiazepines; D020109:Devazepide; D012844:Sincalide